In addition, pharmacological modulation of FcRn by antisense oligonucleotides can restore adipose tissue function and metabolic health in old animals and provide a proof-of-concept for the therapeutic value of other interventions modulating the IgG–FcRn axis in established metabolic diseases with aging (23). Here, FCGRT is linked to metabolic disease.